|
|
||||||||
a Department of Microbiology/Immunology, The Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana, USA;
b Walther Cancer Institute, Indianapolis, Indiana, USA
Key Words. Embryonic stem cells • SDF-1/CXCL12 • Apoptosis • Chemotaxis • Differentiation
Correspondence: Hal E. Broxmeyer, Ph.D., Walther Oncology Center, Indiana University School of Medicine, 1044 West Walnut Street, R4-302, Indianapolis, Indiana 46202, USA. Telephone: 317-274-7510; Fax: 317-274-7592; e-mail: hbroxmey{at}iupui.edu
Understanding embryonic stem cell (ESC) regulation is important for realizing how best to control their growth and differentiation ex vivo for potential therapeutic benefit. Stromal cellderived factor-1 (SDF-1/CXCL12) and its receptor, CXCR4, have been implicated as important regulators of a number of fetal and adult cell functions, including survival/antiapoptosis and migration/homing of hematopoietic stem and progenitor cells. We hypothesized that the SDF-1/CXCL12CXCR4 axis would also be important for regulation of murine ESC functions. ESCs secreted low levels of SDF-1/CXCL12 and expressed low levels of CXCR4; however, both increased with differentiation of ESCs. Endogenously produced/released SDF-1/CXCL12 enhanced survival/antiapoptosis of ESCs in the presence of leukemia inhibitory factor but absence of serum, and survival/antiapoptosis was further enhanced by exogenous administration of SDF-1/CXCL12. Furthermore, SDF-1/CXCL12 induced chemotaxis of ESCs, and chemotaxis could be enhanced by diprotin A inhibition of CD26/dipeptidylpeptidase IV. Endogenous and exogenous SDF-1/CXCL12 enhanced embryoid body production of primitive and definitive erythroid, granulocyte-macrophage, and multipotential progenitors. SDF-1/CXCL12 did not noticeably affect production of hemangioblasts. These results demonstrate functional activities of SDF-1/CXCL12 on survival, chemotaxis, and hematopoietic differentiation of murine ESCs that may be relevant for their ex vivo manipulation.
This article has been cited by other articles:
![]() |
J. L. Hermsen, F. E. Gomez, Y. Maeshima, Y. Sano, W. Kang, and K. A. Kudsk Decreased Enteral Stimulation Alters Mucosal Immune Chemokines JPEN J Parenter Enteral Nutr, January 1, 2008; 32(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Palumbo, B. G. Galvez, T. Pusterla, F. De Marchis, G. Cossu, K. B. Marcu, and M. E. Bianchi Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-{kappa}B activation J. Cell Biol., October 8, 2007; 179(1): 33 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, A. Mora, H. Shim, A. Stecenko, K. L. Brigham, and M. Rojas Role of the SDF-1/CXCR4 Axis in the Pathogenesis of Lung Injury and Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shi, J. Li, L. Liao, B. Chen, B. Li, L. Chen, H. Jia, and R. C. Zhao Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice Haematologica, July 1, 2007; 92(7): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tan, H. Shao, D. Eton, Z. Yang, L. Alonso-Diaz, H. Zhang, A. Schulick, A. S. Livingstone, and H. Yu Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor Cardiovasc Res, March 1, 2007; 73(4): 823 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, Y. Fu, R. A. Charbeneau, T. L. Saunders, D. K. Taylor, K. D. Hankenson, M. W. Russell, L. G. D'Alecy, and R. R. Neubig Pleiotropic Phenotype of a Genomic Knock-In of an RGS-Insensitive G184S Gnai2 Allele. Mol. Cell. Biol., September 1, 2006; 26(18): 6870 - 6879. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, B. Graham-Evans, and H. E. Broxmeyer Murine Embryonic Stem Cells Secrete Cytokines/Growth Modulators That Enhance Cell Survival/Anti-Apoptosis and Stimulate Colony Formation of Murine Hematopoietic Progenitor Cells Stem Cells, April 1, 2006; 24(4): 850 - 856. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
